Welcome to the new Blue Ridge Times website. Thank you for stopping by. Go ahead and bookmark this site for the latest news posted on Monday, Wednesday, and Fridays!
FDA approves BCG vaccine trial for reversing Type I diabetes in phase II tests
The director of the Massachusetts General Hospital Immunology Laboratory, Dr. Denise Faustman at the 75th Scientific Sessions of the American Diabetes Association (ADA) on Sunday announced that the US Food and Drug Administration (FDA) has approved a phase II trial for reversing Type I diabetes using BCG vaccine shots. Dr. Faustman is also an associate professor of Medicine at Harvard Medical School and the lead author of the study, stating that a 5-year trial will commence soon where clinical investigators will evaluate the efficacy of BCG vaccinations for improving the health status of diabetic patients, especially those aged 18-60 and still able to release moderate amounts of insulin via their pancreas. According to Faustman, “We have learned a lot since the early studies in mice – not just about how BCG works but also about its potential therapeutic benefits, similar to what are being seen in trials against other autoimmune diseases.” And then he added that “W...
Comments
Post a Comment